Wells Fargo
IMNM icon

Wells Fargo’s Immunome IMNM Stock Holding History

Wells Fargo’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$913K Sell
41,754
-66,361
-61% -$1.48M ﹤0.01% 3787
2025
Q4 		$2.32M Buy
108,115
+56,700
+110% +$995K ﹤0.01% 3320
2025
Q3 		$602K Buy
51,415
+9,654
+23% +$96K ﹤0.01% 4159
2025
Q2 		$388K Buy
41,761
+5,661
+16% +$46.4K ﹤0.01% 4327
2025
Q1 		$243K Buy
36,100
+9,893
+38% +$94.9K ﹤0.01% 4567
2024
Q4 		$278K Buy
26,207
+8,190
+45% +$99K ﹤0.01% 4583
2024
Q3 		$263K Sell
18,017
-526
-3% -$7.47K ﹤0.01% 4394
2024
Q2 		$224K Buy
18,543
+14,329
+340% +$224K ﹤0.01% 4442
2024
Q1 		$104K Buy
4,214
+2,196
+109% +$44.6K ﹤0.01% 4872
2023
Q4 		$21.6K Buy
2,018
+170
+9% +$1.41K ﹤0.01% 5614
2023
Q3 		$15.4K Sell
1,848
-9
-0.5% -$66 ﹤0.01% 5687
2023
Q2 		$14.7K Buy
1,857
+3
+0.2% +$16 ﹤0.01% 5819
2023
Q1 		$9.25K Buy
1,854
+1
+0.1% +$5 ﹤0.01% 5886
2022
Q4 		$4.09K Buy
1,853
+2
+0.1% +$8 ﹤0.01% 5827
2022
Q3 		$8K Sell
1,851
-1
-0.1% -$5 ﹤0.01% 5762
2022
Q2 		$6K Buy
1,852
+6
+0.3% +$22 ﹤0.01% 5947
2022
Q1 		$10K Buy
1,846
+1,785
+2,926% +$13.3K ﹤0.01% 6266
2021
Q4 		$1K Buy
61
+2
+3% +$36 ﹤0.01% 7021
2021
Q3 		$1K Buy
59
+30
+103% +$523 ﹤0.01% 6718
2021
Q2 		$1K Sell
29
-635
-96% -$14K ﹤0.01% 6672
2021
Q1 		$22K Sell
664
-619
-48% -$15.4K ﹤0.01% 6117
2020
Q4 		$12K Buy
+1,283
New +$15K ﹤0.01% 5982

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Wells Fargo's IMNM Position: Q1 2026 in Review

Wells Fargo reduced its Immunome (IMNM) stake by 61% in Q1 2026, selling an estimated $1.48M and leaving 41,754 shares worth $913K. The position accounts for ﹤0.01% of the portfolio, ranked #3787.

Wells Fargo first reported a position in IMNM in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.32M in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Wells Fargo held 41,754 shares of Immunome worth $913K as of Q1 2026.
  • Wells Fargo sold 66,361 Immunome shares in Q1 2026, an estimated $1.48M.
  • Immunome made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3787 holding.
  • Wells Fargo first reported a position in Immunome in Q4 2020 and has held it in 22 quarters since.
  • Wells Fargo's Immunome position peaked at $2.32M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.